In all countries of the world, chronic obstructive pulmonary disease (COPD) is one of the leading causes of disability and mortality among therapeutic diseases that cause economic and social losses, the level of which is increasing every year. Mortality from COPD ranks fourth in the world in the age group over 45 years. COPD is expected to become the third leading cause of death by 2030. The main category of patients is people of working age (from 40 to 67 years). COPD is often associated with chronic heart failure (CHF) in clinical practice. Both of these diseases are characterized by high morbidity and mortality rates. Such patients require a complex approach to objectively identify both diseases at an early stage. Additional research is needed to provide new information on the pathogenesis and management of patients with COPD and CHF, which will improve quality of life and allow these patients to live longer.
| Mualliflar | Исмаилов Жамшид Абдураимович |
|---|---|
| Jurnal | Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali |
| Nashr sanasi | 2022-10-07 |
| Jild | 3 |
| Son | 3 |
| Til | O‘zbek |
хроническая обструктивная болезнь легких, хроническая сердечная недостаточность, лечение, про-МНП, эндотелий, chronic obstructive pulmonary disease, chronic heart failure, treatment, pro-BNP, endothelium., O‘pkaning surunkali obstruktiv kasalligi, surunkali yurak etishmovchiligi, davolash, pro BNP, endoteliy
This review of the literature is devoted to an actual problem in the field of endicrinology, such as DTG. The main clinical manifestations of DTG associated with an excess of thyroid hormones, affecting…
Our current medicine has been struggling for many years and continues to deal with a decrease in morbidity in the world, and the result of this, as a rule, should be reflected in a decrease in the number of…
Chronic obstructive pulmonary disease (COPD) is now considered a preventable and treatable disease. Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease in patients with bronchial…
Studies in recent years have confirmed that the occurrence of violations in the system of thromboembolism in the pathogenesis of ischemic heart disease and resistance to aspirin almost double the risk of ischemic…
Chronic heart failure (CHF) is a serious problem for all developed countries of the world, despite significant advances in treatment. In recent years, epidemiologic studies have shown an increase in the prevalence of…
This study examined the role of dyslipidemia in the development of coronary heart disease (CHD) in men at a young age. 230 patients with coronary artery disease hospitalized in the departments of somatic resuscitation…
The article presents modern ideas about an integrated approach to the treatment and rehabilitation of coronary heart disease (CHD). The main principles of the treatment of chronic coronary artery disease are given…
This article analyzes the clinical features of the course of unstable angina pectoris in men at a young and old age. The study included 230 patients with unstable angina pectoris, which, depending on the age of the…
Cardiovascular risk factors contribute to the development of cardiovascular disease and their presence may affect the level of microRNA expression in patients with ST-elevation myocardial infarction. So far, only a few…
Antibacterial drugs, as well as their combinations, are widely used in clinical practice. Irrational combinations in antibacterial therapy can lead to adverse drug reactions and/or increased costs in the healthcare…
Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali — barcha maqolalar